×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
ANGO – angiodynamics, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
ANGO
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
1/7
10:51 pm
ango
?????????????????????????????????????????2035????1,417???????????? [CNET News]
Medium
Report
?????????????????????????????????????????2035????1,417???????????? [CNET News]
1/7
07:12 pm
ango
ANGO Stock Dips Despite Q2 Earnings Beat, Gross Margin Improves [Yahoo! Finance]
Medium
Report
ANGO Stock Dips Despite Q2 Earnings Beat, Gross Margin Improves [Yahoo! Finance]
1/6
12:57 pm
ango
AngioDynamics (ANGO) Q1 2026 Earnings Transcript [Yahoo! Finance]
Low
Report
AngioDynamics (ANGO) Q1 2026 Earnings Transcript [Yahoo! Finance]
1/6
12:41 pm
ango
AngioDynamics (ANGO) Q2 2026 Earnings Transcript [Yahoo! Finance]
Low
Report
AngioDynamics (ANGO) Q2 2026 Earnings Transcript [Yahoo! Finance]
1/6
06:21 am
ango
AngioDynamics Reports Fiscal Year 2026 Second Quarter Financial Results; Continued Double Digit Med Tech Growth Drives Increased Profitability [Yahoo! Finance]
High
Report
AngioDynamics Reports Fiscal Year 2026 Second Quarter Financial Results; Continued Double Digit Med Tech Growth Drives Increased Profitability [Yahoo! Finance]
1/6
06:00 am
ango
AngioDynamics Reports Fiscal Year 2026 Second Quarter Financial Results; Continued Double Digit Med Tech Growth Drives Increased Profitability
High
Report
AngioDynamics Reports Fiscal Year 2026 Second Quarter Financial Results; Continued Double Digit Med Tech Growth Drives Increased Profitability
12/29
06:52 pm
ango
AngioDynamics: Growth Remains Under The Radar [Seeking Alpha]
Low
Report
AngioDynamics: Growth Remains Under The Radar [Seeking Alpha]
12/25
05:57 am
ango
AngioDynamics, Inc. (NASDAQ:ANGO): When Will It Breakeven? [Yahoo! Finance]
Low
Report
AngioDynamics, Inc. (NASDAQ:ANGO): When Will It Breakeven? [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
1/8
04:32 pm
ango
Form SCHEDULE 13G/A ANGIODYNAMICS INC Filed by: INTEGRATED CORE STRATEGIES (US) LLC
Low
Report
Form SCHEDULE 13G/A ANGIODYNAMICS INC Filed by: INTEGRATED CORE STRATEGIES (US) LLC
1/6
03:19 pm
ango
Form 10-Q ANGIODYNAMICS INC For: Nov 30
Low
Report
Form 10-Q ANGIODYNAMICS INC For: Nov 30
1/6
07:16 am
ango
Form 8-K ANGIODYNAMICS INC For: Jan 06
High
Report
Form 8-K ANGIODYNAMICS INC For: Jan 06
11/14
04:13 pm
ango
Form SCHEDULE 13G/A ANGIODYNAMICS INC Filed by: Point72 Asset Management, L.P.
Low
Report
Form SCHEDULE 13G/A ANGIODYNAMICS INC Filed by: Point72 Asset Management, L.P.
11/12
07:01 am
ango
Form 8-K ANGIODYNAMICS INC For: Nov 10
Low
Report
Form 8-K ANGIODYNAMICS INC For: Nov 10
10/22
07:00 am
ango
Form 4 ANGIODYNAMICS INC For: Oct 21 Filed by: Weiss Lawrence T
Medium
Report
Form 4 ANGIODYNAMICS INC For: Oct 21 Filed by: Weiss Lawrence T
10/14
06:11 am
ango
Form 4 ANGIODYNAMICS INC For: Oct 13 Filed by: Trowbridge Stephen A
Low
Report
Form 4 ANGIODYNAMICS INC For: Oct 13 Filed by: Trowbridge Stephen A
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
3/17
AngioDynamics, Inc. (NASDAQ: ANGO) was downgraded by analysts at BidaskClub from a "sell" rating to a "strong sell" rating.
14.7%
4/17 AngioDynamics, Inc. (NASDAQ: ANGO) was downgraded by analysts at BidaskClub from a "sell" rating to a "strong sell" rating. 8.1%
3/24 AngioDynamics, Inc. (NASDAQ: ANGO) was upgraded by analysts at BidaskClub from a "strong sell" rating to a "sell" rating. 7.4%
10/28 Form 4 ANGIODYNAMICS INC For: Oct 25 Filed by: Clemmer James C 4.7%
10/3 AngioDynamics, Inc. 2020 Q1 - Results - Earnings Call Slides [Seeking Alpha] 4.5%
7/10 AngioDynamics (ANGO) Q4 2019 Earnings Call Transcript [The Motley Fool] 4.0%
7/10 Q4/2019 5/31/2019 EPS 0.250 ZacksConsensus 0.250 ActVsEst 0.000 - In-Line 2.7%
2/18 Form 4 ANGIODYNAMICS INC For: Feb 12 Filed by: Boucher Brent J. 2.6%
1/6 AngioDynamics to Present at the J.P. Morgan Healthcare Conference 2.5%
1/16 AngioDynamics Launches PATHFINDER I Registry to Evaluate Performance and Clinical Outcomes of the AURYON™ Atherectomy System 2.5%
4/17 AngioDynamics, Inc. (NASDAQ: ANGO) was downgraded by analysts at BidaskClub from a "sell" rating to a "strong sell" rating. 8.1%
3/24 AngioDynamics, Inc. (NASDAQ: ANGO) was upgraded by analysts at BidaskClub from a "strong sell" rating to a "sell" rating. 7.4%
10/28 Form 4 ANGIODYNAMICS INC For: Oct 25 Filed by: Clemmer James C 4.7%
10/3 AngioDynamics, Inc. 2020 Q1 - Results - Earnings Call Slides [Seeking Alpha] 4.5%
7/10 AngioDynamics (ANGO) Q4 2019 Earnings Call Transcript [The Motley Fool] 4.0%
7/10 Q4/2019 5/31/2019 EPS 0.250 ZacksConsensus 0.250 ActVsEst 0.000 - In-Line 2.7%
2/18 Form 4 ANGIODYNAMICS INC For: Feb 12 Filed by: Boucher Brent J. 2.6%
1/6 AngioDynamics to Present at the J.P. Morgan Healthcare Conference 2.5%
1/16 AngioDynamics Launches PATHFINDER I Registry to Evaluate Performance and Clinical Outcomes of the AURYON™ Atherectomy System 2.5%
TOP News Decliners
10/3
AngioDynamics Reports Fiscal 2020 First Quarter Financial Results
-14.4%
1/7 Form 8-K ANGIODYNAMICS INC For: Jan 07 -12.1%
7/10 Form 8-K ANGIODYNAMICS INC For: Jul 10 -10.9%
4/7 AngioDynamics, Inc. (ANGO) CEO Jim Clemmer on Q3 2020 Results - Earnings Call Transcript [Seeking Alpha] -7.5%
3/10 AngioDynamics to Report Fiscal 2020 Third Quarter Financial Results on April 7, 2020 -6.6%
2/7 Form 8-K ANGIODYNAMICS INC For: Feb 05 -5.9%
4/7 Form 4 ANGIODYNAMICS INC For: Apr 04 Filed by: Clemmer James C -4.7%
10/3 Why GoPro, AngioDynamics, and Resources Connection Slumped Today [The Motley Fool] -3.7%
1/21 Form 4 ANGIODYNAMICS INC For: Jan 17 Filed by: Boucher Brent J. -3.6%
10/7 Accelmed seeks to raise $100 million for fourth health tech fund [Reuters] -3.6%
1/7 Form 8-K ANGIODYNAMICS INC For: Jan 07 -12.1%
7/10 Form 8-K ANGIODYNAMICS INC For: Jul 10 -10.9%
4/7 AngioDynamics, Inc. (ANGO) CEO Jim Clemmer on Q3 2020 Results - Earnings Call Transcript [Seeking Alpha] -7.5%
3/10 AngioDynamics to Report Fiscal 2020 Third Quarter Financial Results on April 7, 2020 -6.6%
2/7 Form 8-K ANGIODYNAMICS INC For: Feb 05 -5.9%
4/7 Form 4 ANGIODYNAMICS INC For: Apr 04 Filed by: Clemmer James C -4.7%
10/3 Why GoPro, AngioDynamics, and Resources Connection Slumped Today [The Motley Fool] -3.7%
1/21 Form 4 ANGIODYNAMICS INC For: Jan 17 Filed by: Boucher Brent J. -3.6%
10/7 Accelmed seeks to raise $100 million for fourth health tech fund [Reuters] -3.6%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: